Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in aortic stenosis - Is this the light at the end of the tunnel for patients with aortic stenosis?
The exploratory analysis of FOURIER trial has offered a ray of hope for patients with nonrheumatic aortic stenosis (AS). At present, the only definitive treatment of severe AS is aortic valve replacement (AVR). Despite transaortic valvular replacement revolutionizing the treatment of AS, it still re...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2021-03-01
|
| シリーズ: | Indian Heart Journal |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S0019483221000171 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|